Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7.
Jonathan Ian SilverbergEric L SimpsonJacob Pontoppidan ThyssenThomas WerfelTracy E CardilloStephanie ColvinEvangeline PierceYun-Fei ChenSherry ChenLawrence EichenfieldPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Baricitinib 4-mg and 2-mg combined with TCS maintained clinically meaningful sustained efficacy over 68 weeks of continuous treatment.